A risk model for ovarian carcinoma patients using CA 125: Time to normalization renders second‐look laparotomy redundant

We evaluated the incorporation of CA 125 normalization times into a prognostic model based on pretreatment variables in patients with ovarian carcinoma to determine if they could render second‐look laparotomy (SLL) redundant.

[1]  Use of CA‐125 response to predict survival parameters of patients with advanced ovarian carcinoma , 1994, Acta obstetricia et gynecologica Scandinavica.

[2]  J. Barter,et al.  Second-look laparotomy. , 1994, Seminars in surgical oncology.

[3]  E. Kuşçu,et al.  How does negative clinical evaluation of ovarian carcinoma after full course of chemotherapy correlate with second‐look laparotomy findings? , 1994, Journal of surgical oncology.

[4]  L. Copeland,et al.  Second‐look laparotomy for epithelial ovarian cancer , 1994, Obstetrics and gynecology clinics of North America.

[5]  G. Persico,et al.  Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer. , 1994, Gynecologic oncology.

[6]  G. Facchini,et al.  Intraperitoneal (ip) cisplatin-mitoxantrone-interferon-alpha 2b in ovarian cancer patients with minimal residual disease. , 1993, Gynecologic oncology.

[7]  O. Mogensen.  Prognostic value of CA 125 in advanced ovarian cancer. , 1992, Gynecologic oncology.

[8]  S. Rubin,et al.  Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  H C van Houwelingen,et al.  Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma. , 1990, Cancer research.

[10]  C. Redman,et al.  Early serum CA125 response and outcome in epithelial ovarian cancer. , 1990, European journal of cancer.

[11]  R. Mortel,et al.  Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). , 1989 .

[12]  G. Rustin,et al.  Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Cain,et al.  Recurrence after negative second‐look laparotomy for ovarian cancer: Analysis of risk factors , 1989 .

[14]  J. Neijt,et al.  Predictability of the survival of patients with advanced ovarian cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Rubin,et al.  Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. , 1989 .

[16]  W. Hoskins.  7 The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer , 1989 .

[17]  W. Creasman,et al.  Prognostic factors in relation to second-look laparotomy in ovarian cancer. , 1989, Bailliere's clinical obstetrics and gynaecology.

[18]  W. van Putten,et al.  Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy. , 1988, Gynecologic oncology.

[19]  S. Lippman,et al.  Second‐look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration , 1988, Cancer.

[20]  D. Hedley,et al.  Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Howell,et al.  Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Bast,et al.  CA 125 serum levels correlated with second-look operations among ovarian cancer patients. , 1986, Obstetrics and gynecology.

[23]  N. Geller,et al.  Prognostic factors in advanced ovarian carcinoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  W. Grosh,et al.  Abdominopelvic Computed Tomography: Evaluation in Patients Undergoing Second‐Look Laparotomy for Ovarian Carcinoma , 1985, Obstetrics and gynecology.

[25]  R. Bast,et al.  Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. , 1985, American journal of obstetrics and gynecology.

[26]  J. Spinelli,et al.  Ovarian Carcinoma: A Multivariate Analysis of Prognostic Factors , 1985, Obstetrics and gynecology.

[27]  B. Veress,et al.  Importance of Histologic Grading in the Prognosis of Epithelial Ovarian Carcinoma , 1982, Obstetrics and gynecology.

[28]  Griffiths Ct.  Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .

[29]  D. Cox.  Regression Models and Life-Tables , 1972 .

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .